High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis.

[1]  Jin H. Song,et al.  Interferon γ Induces Neurite Outgrowth by Up-regulation of p35 Neuron-specific Cyclin-dependent Kinase 5 Activator via Activation of ERK1/2 Pathway* , 2005, Journal of Biological Chemistry.

[2]  R. Karas,et al.  High-Density Lipoprotein Cholesterol and Coronary Heart Disease , 2004, Cardiology in review.

[3]  J. Isner,et al.  Estrogen-Mediated, Endothelial Nitric Oxide Synthase–Dependent Mobilization of Bone Marrow–Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury , 2003, Circulation.

[4]  G. Assmann,et al.  Atheroprotective effects of high-density lipoproteins. , 2003, Annual review of medicine.

[5]  C. Heeschen,et al.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells , 2003, Nature Medicine.

[6]  G. Franceschini,et al.  Endothelial Protection by High-Density Lipoproteins: From Bench to Bedside , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[7]  G. Ciuffetti,et al.  Mechanisms of high-density lipoprotein cholesterol effects on the endothelial function in hyperlipemia. , 2003, Metabolism: clinical and experimental.

[8]  A. Zwinderman,et al.  Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin. , 2003, Archives of internal medicine.

[9]  U. Laufs,et al.  Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury , 2003, Circulation research.

[10]  M. Rämet,et al.  High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life. , 2003, Journal of the American College of Cardiology.

[11]  Amir Lerman,et al.  Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events , 2003, Circulation.

[12]  Arshed A. Quyyumi,et al.  Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk , 2003 .

[13]  E. Mannarino,et al.  Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia. , 2002, The American journal of cardiology.

[14]  Jiankun Cui,et al.  S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.

[15]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[16]  R. Karas,et al.  A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. , 2002, American heart journal.

[17]  J. Isner,et al.  Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells , 2002, Circulation.

[18]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[19]  D. Hess,et al.  Bone Marrow as a Source of Endothelial Cells and NeuN-Expressing Cells After Stroke , 2002, Stroke.

[20]  F. Ruschitzka,et al.  High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.

[21]  U. Laufs,et al.  Pleiotropic effects of HMG-CoA reductase inhibitors , 2002, Basic Research in Cardiology.

[22]  Michael Chopp,et al.  Bone Marrow-Derived Endothelial Progenitor Cells Participate in Cerebral Neovascularization After Focal Cerebral Ischemia in the Adult Mouse , 2002, Circulation research.

[23]  S. Verma,et al.  Fundamentals of endothelial function for the clinical cardiologist. , 2002, Circulation.

[24]  J. Genest,et al.  High-Density Lipoproteins and Endothelial Function , 2001, Circulation.

[25]  A. von Eckardstein,et al.  Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids* , 2001, The Journal of Biological Chemistry.

[26]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[27]  Richard G. W. Anderson,et al.  High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase , 2001, Nature Medicine.

[28]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[29]  F. Perticone,et al.  Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.

[30]  M. Trip,et al.  Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial , 2001, The Lancet.

[31]  S. Rafii,et al.  Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells , 2001, Circulation research.

[32]  K. Tsuchida,et al.  High-Density Lipoproteins Protect Endothelial Cells from Tumor Necrosis Factor-α-Induced Apoptosis , 2000 .

[33]  T. Murohara,et al.  Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. , 2000, The Journal of clinical investigation.

[34]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[36]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[37]  S. Kaul,et al.  Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. , 1999, Circulation.

[38]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[39]  J. Wrathall,et al.  Increase of interleukin-1β mRNA and protein in the spinal cord following experimental traumatic injury in the rat , 1997, Brain Research.

[40]  D. Levy,et al.  Lipids and risk of coronary heart disease. The Framingham Study. , 1992, Annals of epidemiology.